The following is an excerpt from Just The News.

The mRNA Covid-19 vaccines made by Pfizer and Moderna showed no reduction in all-cause mortality in randomized controlled trials (RCTs), according to a new paper by researchers at primarily Danish institutions.

“Based on the RCTs with the longest possible follow-up,” mRNA vaccines only protected against “fatal” Covid, while adenovirus-vector vaccines made with older technology, including Johnson & Johnson’s, “were associated with lower overall mortality and lower non-accident, non-Covid-19 mortality,” they wrote.

The research adds to existing questions about the evidentiary basis for vaccine and booster mandates on tens of millions of Americans.

Vaccine experts, including the FDA’s former chief scientist Luciana Borio and current adviser Paul Offit, recently told Stat News they were worried U.S. policy was headed for an annual booster recommendation without data to justify it.

Dozens, including Borio, signed an open letter to top FDA officials last week asking them to recommend “T-cell assessment in Covid-19 vaccine clinical trials” in addition to antibody response, which is often short-lived and has underperformed against Delta and Omicron variants.

Pfizer CEO Albert Bourla has admitted its vaccine hit a brick wall against Omicron.

Citing the “ample evidence” of “broad heterologous effects on the immune system” from Covid vaccines, the paper set out to study “completely unexpected effects on overall mortality” from Covid vaccines that are “different from what could be anticipated based on the protection against the vaccine-targeted disease.”

The researchers identified three RCTs on mRNA vaccines with 74,000 adults and six on adenovirus-vector vaccines with 122,000 that included mortality data 3-4 months after vaccination. 

Sixty-one vaccinated people died compared to 60 placebos in the mRNA RCTs, for an overall risk reduction (RR) of 1.03, a statistically insignificant difference. The paper said the analysis had “low power to detect differences in effect between” the Pfizer and Moderna vaccines.

Sixteen people who received the adenovirus-vector vaccines (J&J, AstraZeneca and Russia’s Sputnik) died, compared to 30 in the control group, for a highly significant overall RR of 0.37. Individually, the RRs were 0.19 for J&J and 0.50 for AstraZeneca, but Sputnik had too few deaths to confidently discern any difference. 

Pfizer and Moderna didn’t answer queries to respond to the research. Neither did the CDC or FDA when asked why they hadn’t funded or sought research to determine whether mRNA COVID vaccines actually save lives, continuing a pattern of getting upstaged by Covid research from abroad.

Read full article here.